Skip to main content
. 2017 Jan 23;12(1):e0170291. doi: 10.1371/journal.pone.0170291

Fig 6. Interferon(IFN)-γ enzyme-linked immunospot assays of PBMCs to SART3-derived peptide (SART3109) or control peptides (CMVpp65328) in HCC patients with RFA and SART3109 peptide vaccination.

Fig 6

White and black bars show the T-cell responses before and after vaccination, respectively. An asterisk denotes more than 50 specific spots.